| Interactions between the immune system and cancer: a brief review of non-spatial mathematical models R Eftimie, JL Bramson, DJD Earn Bulletin of mathematical biology 73, 2-32, 2011 | 488 | 2011 |
| TNF-α is a critical negative regulator of type 1 immune activation during intracellular bacterial infection A Zganiacz, M Santosuosso, J Wang, T Yang, L Chen, M Anzulovic, ... The Journal of clinical investigation 113 (3), 401-413, 2004 | 272 | 2004 |
| Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of … JL Bramson, M Hitt, CL Addison, WJ Muller, J Gauldie, FL Graham Human gene therapy 7 (16), 1995-2002, 1996 | 239 | 1996 |
| IL-12 gene therapy protects mice in lethal Klebsiella pneumonia. MJ Greenberger, SL Kunkel, RM Strieter, NW Lukacs, J Bramson, ... Journal of immunology (Baltimore, Md.: 1950) 157 (7), 3006-3012, 1996 | 237 | 1996 |
| Blood CD33 (+) HLA-DR (−) myeloid-derived suppressor cells are increased with age and a history of cancer CP Verschoor, J Johnstone, J Millar, MG Dorrington, M Habibagahi, ... Journal of leukocyte biology 93 (4), 633-637, 2013 | 233 | 2013 |
| A human type 5 adenovirus–based tuberculosis vaccine induces robust T cell responses in humans despite preexisting anti-adenovirus immunity F Smaill, M Jeyanathan, M Smieja, MF Medina, N Thanthrige-Don, ... Science translational medicine 5 (205), 205ra134-205ra134, 2013 | 227 | 2013 |
| Induction of epitope-specific neutralizing antibodies against West Nile virus T Oliphant, GE Nybakken, SK Austin, Q Xu, J Bramson, M Loeb, ... Journal of virology 81 (21), 11828-11839, 2007 | 220 | 2007 |
| Potentiating cancer immunotherapy using an oncolytic virus BW Bridle, KB Stephenson, JE Boudreau, S Koshy, N Kazdhan, ... Molecular Therapy 18 (8), 1430-1439, 2010 | 218 | 2010 |
| Maraba virus as a potent oncolytic vaccine vector JG Pol, L Zhang, BW Bridle, KB Stephenson, J Rességuier, S Hanson, ... Molecular therapy 22 (2), 420-429, 2014 | 195 | 2014 |
| Defining the critical hurdles in cancer immunotherapy BA Fox, DJ Schendel, LH Butterfield, S Aamdal, JP Allison, PA Ascierto, ... Journal of translational medicine 9, 1-15, 2011 | 192 | 2011 |
| The use of adenoviral vectors for gene therapy and gene transfer in vivo JL Bramson, FL Graham, J Gauldie Current opinion in biotechnology 6 (5), 590-595, 1995 | 192 | 1995 |
| Dendritic cells transduced with an adenoviral vector encoding a model tumor-associated antigen for tumor vaccination Y Wan, J Bramson, R Carter, F Graham, J Gauldie Human gene therapy 8 (11), 1355-1363, 1997 | 191 | 1997 |
| Antigen presentation by exosomes released from peptide-pulsed dendritic cells is not suppressed by the presence of active CTL L Luketic, J Delanghe, PT Sobol, P Yang, E Frotten, KL Mossman, ... The Journal of Immunology 179 (8), 5024-5032, 2007 | 186 | 2007 |
| Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties M François, R Romieu-Mourez, S Stock-Martineau, MN Boivin, ... Blood, The Journal of the American Society of Hematology 114 (13), 2632-2638, 2009 | 177 | 2009 |
| IL-1α/IL-1R1 expression in chronic obstructive pulmonary disease and mechanistic relevance to smoke-induced neutrophilia in mice FM Botelho, CMT Bauer, D Finch, JK Nikota, CCJ Zavitz, A Kelly, ... PloS one 6 (12), e28457, 2011 | 176 | 2011 |
| A switch in costimulation from CD28 to 4-1BB during primary versus secondary CD8 T cell response to influenza in vivo EM Bertram, W Dawicki, B Sedgmen, JL Bramson, DH Lynch, TH Watts The Journal of Immunology 172 (2), 981-988, 2004 | 174 | 2004 |
| Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines J Bramson, K Dayball, C Evelegh, YH Wan, D Page, A Smith Gene therapy 10 (3), 251-260, 2003 | 171 | 2003 |
| The rational development of CD133-targeting immunotherapies for glioblastoma P Vora, C Venugopal, SK Salim, N Tatari, D Bakhshinyan, M Singh, ... Cell Stem Cell 26 (6), 832-844. e6, 2020 | 148 | 2020 |
| Construction of a Double Recombinant Adenovirus Vector Expressing a Heterodimeric Cytokine: In Vitro and In Vivo Production of Biologically Active Interleukin-12 J Bramson, M Hitt, WS Gallichan, KL Rosenthal, J Gauldie, FL Graham Human Gene Therapy 7 (3), 333-342, 1996 | 147 | 1996 |
| Pre-existing immunity to adenovirus does not prevent tumor regression following intratumoral administration of a vector expressing IL-12 but inhibits virus dissemination JL Bramson, M Hitt, J Gauldie, FL Graham Gene therapy 4 (10), 1069-1076, 1997 | 142 | 1997 |
